drugset / Trial / NCT00951899
The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics
Phase 4
Completed
38 enrolled
Mayo Clinic
Daiichi Sankyo · collabNational Center for Research Resources (NCRR) · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The goal of this study was to determine the metabolic mechanism for a certain type medication's ability to lower blood sugar after a meal in Type 2 Diabetics, in order to develop a better understanding of it's potential role in the treatment of obesity.
Timeline
- Start
- 2009-08
- Primary completion
- 2012-07
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colesevelam | Other / unclassified | 1875 mg | Oral |
| Background | Metformin | Small molecule | 500 mg | Oral |